SG46307A1 - New pyrazine derivatives the preparation and use thereof - Google Patents

New pyrazine derivatives the preparation and use thereof

Info

Publication number
SG46307A1
SG46307A1 SG1996002613A SG1996002613A SG46307A1 SG 46307 A1 SG46307 A1 SG 46307A1 SG 1996002613 A SG1996002613 A SG 1996002613A SG 1996002613 A SG1996002613 A SG 1996002613A SG 46307 A1 SG46307 A1 SG 46307A1
Authority
SG
Singapore
Prior art keywords
preparation
pyrazine derivatives
new pyrazine
new
compounds
Prior art date
Application number
SG1996002613A
Other languages
English (en)
Inventor
Herbert Koppe
Georg Speck
Klaus Stockhaus
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4127026A external-priority patent/DE4127026A1/de
Priority claimed from DE19914130461 external-priority patent/DE4130461A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SG46307A1 publication Critical patent/SG46307A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG1996002613A 1991-08-16 1992-07-31 New pyrazine derivatives the preparation and use thereof SG46307A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4127026A DE4127026A1 (de) 1991-08-16 1991-08-16 Neue pyrazinderivate, ihre herstellung und verwendung
DE19914130461 DE4130461A1 (de) 1991-09-13 1991-09-13 Neue pyrazinderivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
SG46307A1 true SG46307A1 (en) 1998-02-20

Family

ID=25906394

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002613A SG46307A1 (en) 1991-08-16 1992-07-31 New pyrazine derivatives the preparation and use thereof

Country Status (23)

Country Link
EP (1) EP0598770B1 (fr)
JP (1) JPH06509798A (fr)
AT (1) ATE159250T1 (fr)
AU (1) AU669122B2 (fr)
CA (1) CA2115755A1 (fr)
CZ (1) CZ280760B6 (fr)
DE (1) DE59208974D1 (fr)
DK (1) DK0598770T3 (fr)
ES (1) ES2108129T3 (fr)
FI (1) FI940696A (fr)
GR (1) GR3025742T3 (fr)
HK (1) HK1003137A1 (fr)
HU (1) HUT67661A (fr)
IE (1) IE922592A1 (fr)
IL (1) IL102814A0 (fr)
MX (1) MX9204637A (fr)
NO (1) NO301542B1 (fr)
NZ (1) NZ243959A (fr)
RU (1) RU2124008C1 (fr)
SG (1) SG46307A1 (fr)
SK (1) SK17594A3 (fr)
TW (1) TW213903B (fr)
WO (1) WO1993004048A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645969B1 (en) 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
DE4337609A1 (de) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5760230A (en) * 1996-10-11 1998-06-02 Bayer Aktiengesellschaft 4, 4'-bridged bis-2, 4-diaminoquinazolines
US6420354B1 (en) * 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
AU4952700A (en) 1999-06-03 2000-12-28 Takeda Chemical Industries Ltd. Pernasal preparations
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
EP1485364B1 (fr) * 2002-03-13 2009-03-11 Janssen Pharmaceutica N.V. Derives aminocarbonyl utilises en tant que nouveaux inhibiteurs d'histone deacetylase
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
AU2004270162B2 (en) 2003-08-28 2010-05-13 Nicox S.A. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (fr) 2005-01-03 2006-07-13 Myriad Genetics Inc. Composes et utilisation therapeutique associee
CA2597460A1 (fr) 2005-02-24 2006-08-31 Nitromed, Inc. Compositions et composes diuretiques renforcateurs d'oxyde nitrique, et leurs procedes d'utilisation
DE102008061247A1 (de) 2008-12-10 2010-06-24 Christian-Albrechts-Universität Zu Kiel Inhibitoren der Dimethylarginin Dimethylaminohydrolase
JP5695200B2 (ja) * 2010-09-10 2015-04-01 ハンジョウ ベンシェン ファーマシューティカル シーオー．， エルティーディー．Ｈａｎｇｚｈｏｕ Ｂｅｎｓｈｅｎｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． 複素環アミノベルバミン誘導体、その調製方法及び使用
CN110041291B (zh) * 2018-01-15 2021-02-26 北京采瑞医药科技研究院有限公司 一种玛咖酰胺衍生物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639386A (fr) * 1962-10-30
US3527758A (en) * 1967-04-13 1970-09-08 Merck & Co Inc Process for the preparation of pyrazinoylguanidines from a pyrazinoic azide and a guanidine
US3539569A (en) * 1968-08-21 1970-11-10 Merck & Co Inc Preparation of pyrazinoylguanidines from pyrazinoylureas
NL7803906A (nl) * 1978-04-12 1979-10-16 Noordvos Schroeven Bv Werkwijze, inrichting en propeller voor het verdelen van een gasvormig, poedervormig of vloeibaar materiaal in een vloeistof.

Also Published As

Publication number Publication date
NO301542B1 (no) 1997-11-10
EP0598770A1 (fr) 1994-06-01
FI940696A0 (fi) 1994-02-15
CZ280760B6 (cs) 1996-04-17
NZ243959A (en) 1995-07-26
TW213903B (fr) 1993-10-01
SK17594A3 (en) 1994-12-07
CA2115755A1 (fr) 1993-03-04
GR3025742T3 (en) 1998-03-31
EP0598770B1 (fr) 1997-10-15
NO940523L (no) 1994-02-15
CZ33794A3 (en) 1994-07-13
IL102814A0 (en) 1993-01-31
NO940523D0 (no) 1994-02-15
DK0598770T3 (da) 1997-12-15
AU669122B2 (en) 1996-05-30
HUT67661A (en) 1995-04-28
RU2124008C1 (ru) 1998-12-27
HK1003137A1 (en) 1998-10-09
DE59208974D1 (de) 1997-11-20
MX9204637A (es) 1993-02-01
ES2108129T3 (es) 1997-12-16
WO1993004048A1 (fr) 1993-03-04
HU9400430D0 (en) 1994-05-30
JPH06509798A (ja) 1994-11-02
AU2387092A (en) 1993-03-16
IE922592A1 (en) 1993-02-24
RU94015265A (ru) 1997-02-20
FI940696A (fi) 1994-02-15
ATE159250T1 (de) 1997-11-15

Similar Documents

Publication Publication Date Title
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
IL76457A0 (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
PT83647A (en) Process for the preparation of novel pharmaceutical benzimidazole derivatives and of pharmaceutical compositions containing the same
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
HU906007D0 (en) Process for the preparation of pyrimidine-4,6-dicarbonic acid-diamides and medical preparations containing them as active agents
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
AU8240387A (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
AU1891683A (en) Substituted 1-phenyl-isoquinoline anti-arrythmic agents
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
EP0314984A3 (fr) Application des dérivés de la 2-pyrimidinyl-1-pipérazine
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
CA2119661A1 (fr) Nouveaux composes de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant
AU641950B2 (en) (1R,2R)-2-(3-pyridyl)-tetrahydrothiopyran-2-carbothioamide 1-oxides, process for their preparation and pharmaceutical compositions containing them
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
HUT57227A (en) 2'-dezamino-4'-desoxy-4'-amino-8-fluoro-anthracycline derivatives, process for producing them as well as pharmaceutical preparatives containing said compounds as active substance
IL100128A0 (en) Pharmaceutical compositions containing an imidazobenzodiazepine
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them
HUT60495A (en) Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds
IT1254256B (it) Derivati di idroisochinolina
ZA879578B (en) Dibenzo(be)oxepinacetic acid derivatives,their preparation and pharmaceutical compositions containing them